Intelligent Total Stockholder Equity vs Cash And Short Term Investments Analysis

INBS Stock

USD 2.20 0.09 3.93%

Intelligent Bio financial indicator trend analysis is infinitely more than just investigating Intelligent Bio Solutions recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intelligent Bio Solutions is a good investment. Please check the relationship between Intelligent Bio Total Stockholder Equity and its Cash And Short Term Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Total Stockholder Equity vs Cash And Short Term Investments

Total Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intelligent Bio Solutions Total Stockholder Equity account and Cash And Short Term Investments. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Intelligent Bio's Total Stockholder Equity and Cash And Short Term Investments is 0.97. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Intelligent Bio Solutions, assuming nothing else is changed. The correlation between historical values of Intelligent Bio's Total Stockholder Equity and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Intelligent Bio Solutions are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Stockholder Equity i.e., Intelligent Bio's Total Stockholder Equity and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Intelligent Bio Solutions balance sheet. This account contains Intelligent Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Intelligent Bio Solutions fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Intelligent Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Selling General Administrative is likely to drop to about 4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.4 M in 2024

Intelligent Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Common Stock Shares Outstanding	Inventory	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Invested Capital	Short Long Term Debt
Total Assets		-0.8	-0.77	-0.91	0.97	-0.96	-0.87	0.79	0.99	0.99	-0.65	0.66	0.9	-0.37	1.0	-0.86	-0.1	0.99	0.33	-0.96	0.94	0.38	-0.82	0.77	0.96	-0.93
Short Long Term Debt Total	-0.8		0.47	0.84	-0.86	0.92	0.71	-0.76	-0.84	-0.84	0.95	-0.51	-0.93	0.55	-0.8	0.99	0.5	-0.86	-0.36	0.77	-0.74	-0.33	0.63	-0.48	-0.9	0.91
Other Current Liab	-0.77	0.47		0.81	-0.79	0.7	0.83	-0.8	-0.73	-0.73	0.4	-0.31	-0.72	0.6	-0.79	0.54	-0.13	-0.71	-0.14	0.69	-0.67	-0.23	0.64	-0.56	-0.74	0.75
Total Current Liabilities	-0.91	0.84	0.81		-0.94	0.93	0.79	-0.8	-0.91	-0.91	0.75	-0.56	-0.92	0.68	-0.91	0.88	0.37	-0.91	-0.3	0.87	-0.78	-0.5	0.63	-0.5	-0.95	0.92
Total Stockholder Equity	0.97	-0.86	-0.79	-0.94		-0.99	-0.89	0.87	0.97	0.97	-0.74	0.62	0.96	-0.49	0.97	-0.91	-0.16	0.97	0.32	-0.95	0.93	0.37	-0.83	0.74	0.99	-0.97
Net Debt	-0.96	0.92	0.7	0.93	-0.99		0.87	-0.83	-0.97	-0.97	0.81	-0.62	-0.97	0.47	-0.96	0.96	0.25	-0.98	-0.38	0.93	-0.92	-0.37	0.8	-0.7	-1.0	0.98
Retained Earnings	-0.87	0.71	0.83	0.79	-0.89	0.87		-0.84	-0.86	-0.86	0.68	-0.26	-0.9	0.48	-0.89	0.76	-0.16	-0.86	-0.45	0.76	-0.88	0.04	0.9	-0.79	-0.87	0.92
Accounts Payable	0.79	-0.76	-0.8	-0.8	0.87	-0.83	-0.84		0.79	0.79	-0.7	0.42	0.89	-0.57	0.8	-0.79	-0.01	0.77	0.01	-0.74	0.71	0.19	-0.76	0.62	0.83	-0.88
Cash	0.99	-0.84	-0.73	-0.91	0.97	-0.97	-0.86	0.79		1.0	-0.71	0.64	0.92	-0.39	0.99	-0.89	-0.17	0.99	0.35	-0.94	0.93	0.37	-0.81	0.74	0.97	-0.94
Cash And Short Term Investments	0.99	-0.84	-0.73	-0.91	0.97	-0.97	-0.86	0.79	1.0		-0.71	0.64	0.92	-0.39	0.99	-0.89	-0.17	0.99	0.35	-0.94	0.93	0.37	-0.81	0.74	0.97	-0.94
Non Current Liabilities Total	-0.65	0.95	0.4	0.75	-0.74	0.81	0.68	-0.7	-0.71	-0.71		-0.24	-0.89	0.67	-0.67	0.93	0.52	-0.73	-0.41	0.57	-0.6	-0.1	0.57	-0.36	-0.79	0.86
Other Current Assets	0.66	-0.51	-0.31	-0.56	0.62	-0.62	-0.26	0.42	0.64	0.64	-0.24		0.45	0.12	0.62	-0.56	-0.27	0.63	-0.17	-0.82	0.59	0.82	-0.38	0.47	0.62	-0.46
Other Stockholder Equity	0.9	-0.93	-0.72	-0.92	0.96	-0.97	-0.9	0.89	0.92	0.92	-0.89	0.45		-0.62	0.91	-0.96	-0.24	0.92	0.38	-0.84	0.86	0.22	-0.8	0.66	0.97	-1.0
Total Liab	-0.37	0.55	0.6	0.68	-0.49	0.47	0.48	-0.57	-0.39	-0.39	0.67	0.12	-0.62		-0.4	0.53	0.45	-0.4	-0.22	0.24	-0.2	-0.1	0.19	0.05	-0.49	0.58
Total Current Assets	1.0	-0.8	-0.79	-0.91	0.97	-0.96	-0.89	0.8	0.99	0.99	-0.67	0.62	0.91	-0.4		-0.86	-0.1	0.99	0.35	-0.94	0.94	0.35	-0.83	0.77	0.96	-0.94
Short Term Debt	-0.86	0.99	0.54	0.88	-0.91	0.96	0.76	-0.79	-0.89	-0.89	0.93	-0.56	-0.96	0.53	-0.86		0.44	-0.91	-0.36	0.83	-0.8	-0.36	0.69	-0.55	-0.94	0.95
Common Stock	-0.1	0.5	-0.13	0.37	-0.16	0.25	-0.16	-0.01	-0.17	-0.17	0.52	-0.27	-0.24	0.45	-0.1	0.44		-0.18	-0.06	0.14	0.07	-0.53	-0.28	0.39	-0.24	0.2
Net Receivables	0.99	-0.86	-0.71	-0.91	0.97	-0.98	-0.86	0.77	0.99	0.99	-0.73	0.63	0.92	-0.4	0.99	-0.91	-0.18		0.44	-0.95	0.94	0.38	-0.8	0.73	0.98	-0.95
Common Stock Shares Outstanding	0.33	-0.36	-0.14	-0.3	0.32	-0.38	-0.45	0.01	0.35	0.35	-0.41	-0.17	0.38	-0.22	0.35	-0.36	-0.06	0.44		-0.23	0.44	-0.16	-0.3	0.22	0.38	-0.41
Inventory	-0.96	0.77	0.69	0.87	-0.95	0.93	0.76	-0.74	-0.94	-0.94	0.57	-0.82	-0.84	0.24	-0.94	0.83	0.14	-0.95	-0.23		-0.93	-0.55	0.77	-0.75	-0.94	0.86
Net Tangible Assets	0.94	-0.74	-0.67	-0.78	0.93	-0.92	-0.88	0.71	0.93	0.93	-0.6	0.59	0.86	-0.2	0.94	-0.8	0.07	0.94	0.44	-0.93		0.22	-0.92	0.9	0.91	-0.89
Non Current Assets Total	0.38	-0.33	-0.23	-0.5	0.37	-0.37	0.04	0.19	0.37	0.37	-0.1	0.82	0.22	-0.1	0.35	-0.36	-0.53	0.38	-0.16	-0.55	0.22		0.09	-0.05	0.41	-0.22
Non Currrent Assets Other	-0.82	0.63	0.64	0.63	-0.83	0.8	0.9	-0.76	-0.81	-0.81	0.57	-0.38	-0.8	0.19	-0.83	0.69	-0.28	-0.8	-0.3	0.77	-0.92	0.09		-0.96	-0.79	0.83
Other Assets	0.77	-0.48	-0.56	-0.5	0.74	-0.7	-0.79	0.62	0.74	0.74	-0.36	0.47	0.66	0.05	0.77	-0.55	0.39	0.73	0.22	-0.75	0.9	-0.05	-0.96		0.69	-0.69
Net Invested Capital	0.96	-0.9	-0.74	-0.95	0.99	-1.0	-0.87	0.83	0.97	0.97	-0.79	0.62	0.97	-0.49	0.96	-0.94	-0.24	0.98	0.38	-0.94	0.91	0.41	-0.79	0.69		-0.98
Short Long Term Debt	-0.93	0.91	0.75	0.92	-0.97	0.98	0.92	-0.88	-0.94	-0.94	0.86	-0.46	-1.0	0.58	-0.94	0.95	0.2	-0.95	-0.41	0.86	-0.89	-0.22	0.83	-0.69	-0.98

Click cells to compare fundamentals

Intelligent Bio Account Relationship Matchups

Intelligent Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.3M	2.5M	20.4M	12.4M	14.2M	8.3M
Short Long Term Debt Total	4.8M	5.1M	5.1M	1.3M	1.2M	1.1M
Other Current Liab	2.1M	(21.8K)	1.1M	201.3K	181.2K	172.1K
Total Current Liabilities	6.3M	7.7M	3.7M	4.7M	4.2M	4.5M
Total Stockholder Equity	(4.6M)	(5.2M)	13.6M	6.6M	7.6M	8.0M
Net Debt	4.9M	4.7M	(12.6M)	(8.2M)	(7.4M)	(7.0M)
Retained Earnings	(12.7M)	(15.8M)	(24.3M)	(31.2M)	(28.1M)	(26.7M)
Accounts Payable	483.6K	1.5M	715.9K	1.6M	1.9M	2.0M
Cash	197.9K	427.3K	12.6M	8.2M	9.5M	4.7M
Cash And Short Term Investments	197.9K	427.3K	12.6M	8.2M	9.5M	4.7M
Liabilities And Stockholders Equity	2.5M	20.4M	12.4M	12.4M	14.2M	8.4M
Non Current Liabilities Total	6.0M	5.6M	3.2M	1.1M	1.0M	977.6K
Other Current Assets	12.1K	3.8M	163.1K	746.8K	858.8K	850.3K
Other Stockholder Equity	(8.7M)	(9.2M)	38.4M	38.4M	44.2M	46.4M
Total Liab	6.3M	7.7M	6.9M	5.8M	5.2M	5.1M
Total Current Assets	2.3M	2.3M	16.4M	10.9M	12.5M	7.2M
Accumulated Other Comprehensive Income	(216.9K)	(364.0K)	(661.3K)	(788.1K)	(709.3K)	(673.9K)
Short Term Debt	5.1M	5.1M	137.8K	576.7K	519.0K	493.0K
Common Stock	2.0M	2.9M	142.3K	148.9K	134.0K	127.3K
Net Receivables	19.6K	3.2M	2.5M	1.9M	2.2M	1.4M
Inventory	1.9M	(3.2M)	0.0	1.0	0.9	0.86
Net Tangible Assets	(5.2M)	15.0M	6.6M	(1.5M)	(1.7M)	(1.8M)
Net Invested Capital	(17.4M)	15.0M	6.6M	4.6M	5.2M	5.5M
Capital Stock	20.2M	148.8K	148.9K	23.3K	21.0K	19.9K
Net Working Capital	(5.4M)	14.5M	6.2M	(2.0M)	(2.3M)	(2.2M)

Pair Trading with Intelligent Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Intelligent Stock

0.86	DH	Definitive Healthcare Buyout Trend	Pair Corr
0.93	ABT	Abbott Laboratories Financial Report 18th of July 2024	Pair Corr

Moving against Intelligent Stock

0.82	BSX	Boston Scientific Corp	Pair Corr
0.73	ELV	Elevance Health Financial Report 17th of July 2024	Pair Corr
0.46	UNH	UnitedHealth Group Financial Report 12th of July 2024	Pair Corr

The ability to find closely correlated positions to Intelligent Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Bio Solutions to buy it.

The correlation of Intelligent Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Bio Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Intelligent Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC